Geneseq Biosciences is a Melbourne based biotechnology company.
We are pioneering the development of new “liquid biopsy” tests to help doctors individualise cancer diagnostics & treatment options.
Our first test, Melaseq, is designed to accurately detect the genomic (microRNA) fingerprint of invasive melanoma in blood and solid biopsy tissue.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Melbourne, Vic 3004, Au
- in****@****.com.au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- geneseq.com.au
- Keywords
- MicroRNA, Cancer, Diagnostics, Liquid Biopsy, Bioinformatics, Translational science, Prognostics, Treatment response prediction, Patient access.
- HQ
- Melbourne, VIC
Geneseq Biosciences Questions
Geneseq Biosciences's website is geneseq.com.au
Geneseq Biosciences's LinkedIn profile is https://au.linkedin.com/company/geneseq-biosciences
Geneseq Biosciences has
3 employees.
View email and phone details for 3
employees at Geneseq Biosciences.
Geneseq Biosciences's industry is
Biotechnology Research
Geneseq Biosciences's top competitors are
Abacbs - Australian Bioinformatics And Computational Biology Society,
Geneseq Sdn Bhd,
Tell Touch,
Lab-Ind Resource Sdn Bhd,
Australian Clinical Labs,
Cptoys,
T8tonsley,
Relevare Pharmaceuticals Ltd.,
Microbiom,
Imaq Research Inc.
Geneseq Biosciences's support email address is info@geneseq.com.au
Geneseq Biosciences's categories are Biotechnology Research
Geneseq Biosciences's founding year is 2017
